Loading chat...

CT SB00162

Bill

Official Source

Status

Introduced

2/21/2024

Primary Sponsor

Saud Anwar

Click for details

Origin

Senate

2024 General Assembly

AI Summary

  • Amends Title 12 of Connecticut general statutes to create tax incentives for pharmaceutical manufacturers operating in the state
  • Provides tax incentives specifically for sterile compounding pharmacies that compound essential drugs in Connecticut
  • Aims to encourage in-state production and compounding of essential prescription medications
  • Referred to the Committee on Finance, Revenue and Bonding for the February 2024 session

Legislative Description

An Act Establishing Tax Incentives To Support Prescription Drug Compounding.

Last Action

Referred to Joint Committee on Finance, Revenue and Bonding

2/21/2024

Committee Referrals

Finance, Revenue and Bonding2/21/2024

Full Bill Text

No bill text available